Clonidine Transdermal Patch and Buprenorphine: Interaction Details
Medically reviewed by Dr. Brian Staiger, PharmD, BCPS
Also reviewed by the HelloPharmacist Editorial Team Updated AI-assisted Details about this page
- Dr. Brian Staiger, PharmD, BCPS, is a clinical pharmacist and pharmacotherapy specialist.
- AI-assisted, written
- AI is used only to summarize verified clinical information, never the open internet.
- Editorial policy
- How we build our interaction pages →
- Our AI policy →
A close look at the Clonidine Transdermal Patch and Buprenorphine interaction:
Buprenorphine
- Butrans
- Belbuca
- Sublocade
- Buprenex
- Brixadi
Clonidine Transdermal Patch
- Catapres-TTS
- Kapvay
- Nexiclon
- Onyda
- Javadin
- Qlonilik
- Duraclon
- Catapres
- Catapres-TTS-1
- Catapres-TTS-2
- Catapres-TTS-3
What Happens When You Take Clonidine Transdermal Patch With Buprenorphine
What can happen when they are taken together (rated Moderate)
An increased risk of and somnolence
Interaction Deep Dive
A note from Dr. Brian Staiger If you’re a patient, this deep dive may be too technical, or bore you (or both). Read the plain-language explanation →
of cloNIDine with other depressants should be avoided,2 since the combination may intensify sedative effects.21
The Clonidine Transdermal Patch and Buprenorphine Interaction, Explained
Buprenorphine is an used for pain or to treat opioid use disorder, and it can make you feel sleepy. The clonidine patch lowers blood pressure, and it often causes drowsiness too. When you use both, the sleepy effects can add together. You might feel more tired, foggy, or slow than usual.
This warning is based on how the two drugs work, not on studies showing problems. Still, be careful driving or doing anything that needs focus until you know how you feel. Your care team can manage this by watching how you do and tailoring your treatment. Talk with your pharmacist or doctor if you feel very drowsy.
Mechanism: . Buprenorphine (partial mu-opioid ) and clonidine (central alpha-2 adrenergic agonist) each produce and somnolence. No interaction is expected.
- Direction: Increased sedation and somnolence. Magnitude not quantified.
- Onset: Unspecified.
- Evidence: Theoretical. Clonidine labeling advises avoiding depressants.
- Management: Avoid combination where feasible. If coadministered, monitor for excessive sedation, and consider additive and . Individualize dosing, counsel on driving and alcohol, and reassess if sedation is excessive.
See the 2 references behind this explanation ↓
From the HelloPharmacist Pharmacy Team
AI-assisted: written with AI from this pair’s record in our interaction database, and reviewed by the HelloPharmacist pharmacy team. Written .
How we build these pages · How we use AI · Our editorial policy
Why Clonidine Transdermal Patch and Buprenorphine Interact
The likely mechanism
sedative effects
How to Manage the Clonidine Transdermal Patch and Buprenorphine Interaction
The documented guidance is to avoid using clonidine with other medicines that cause drowsiness when possible, because the sleepiness can add up.
- Your care team may decide whether this combination is right for you, or choose another option.
- If you use both, your team may monitor you more closely and adjust and individualize your doses.
- Keep using both as prescribed. Do not stop the clonidine patch suddenly on your own.
- Tell your pharmacist or prescriber if you feel very sleepy, confused, or dizzy, and avoid alcohol and driving until you know how you react.
Management is individual — confirm any change with your pharmacist or prescriber.
Questions for Your Pharmacist
- Does my dose of Clonidine Transdermal Patch or Buprenorphine need adjusting while I take them together?
- What symptoms should prompt me to call you or my prescriber right away?
- Does the timing of my doses matter for this combination?
- Is there anything you'd monitor while I'm on both?
Clonidine Transdermal Patch and Buprenorphine: Common Questions
How serious is the Clonidine Transdermal Patch and Buprenorphine interaction?
It is rated moderate. Can be significant — usually manageable with monitoring.
How is the Clonidine Transdermal Patch and Buprenorphine interaction managed?
The documented guidance is to avoid using clonidine with other medicines that cause drowsiness when possible, because the sleepiness can add up. Your care team may decide whether this combination is right for you, or choose another option. If you use both, your team may monitor you more closely and adjust and individualize your doses. Keep using both as prescribed. Do not stop the clonidine patch… Management is individual — always follow your own care team's guidance.
How quickly could this interaction happen?
The documented onset is "unspecified". The timing of this interaction is not well characterized.
How strong is the evidence for this interaction?
The evidence is graded "theoretical". Expected from how the drugs work, or from studies of similar drugs; this exact pair has little direct study.
Ask About the Clonidine Transdermal Patch and Buprenorphine Interaction
Ask in your own words about taking Clonidine Transdermal Patch and Buprenorphine together. The answer comes from this page’s interaction record and both drugs’ own information.
This box answers questions about this one combination only. For anything else about either drug, open its drug information page or ask a pharmacist.
AI answers from this page’s record and both drugs’ information, never the open internet. AI can make mistakes, so always check with your doctor or pharmacist.
References (2)
- Product Information: NEXICLON(TM) XR extended-release oral tablets, clonidine extended-release oral tablets. Athena Bioscience, LLC (per DailyMed), Athens, GA, 2022. DailyMed
- Product Information: ONYDA(TM) XR extended release suspension, clonidine hydrochloride extended release suspension. Tris Pharma, Inc (Per FDA), Monmouth Junction, NJ, 2024.
Other Serious Interactions of Clonidine Transdermal Patch and Buprenorphine
Also serious with Buprenorphine
- DronedaroneContraindicated
- FluconazoleContraindicated
- IsocarboxazidContraindicated
- KetoconazoleContraindicated
Also serious with Clonidine Transdermal Patch
These Medications Also Interact With Supplements
Prescription drugs aren't the whole picture — herbal and dietary supplements can interact with them too. From the evidence-graded Natural Medicines database:
With Buprenorphine
- GrapefruitMajor
- St. John's WortMajor
- Activated CharcoalMajor
- KavaMajor
- WineMajor
- 1,4-butanediolMajor
- BeerMajor
- Gamma-hydroxybutyrate (GHB)Major
- + 210 more
Check everything you take with our drug–supplement interaction checker.
Still Have Questions About This Combination?
Every question gets a real answer from a licensed pharmacist — free, as soon as they can.
About This Library
Built in-house, documented one interaction at a time. Our interaction database is not a complete list of every known interaction: a combination that isn't listed here hasn't been documented by us yet, which never means it's safe. Checking everything you take at once? Ask your pharmacist to review your full medication list. How we build and review it →
What Each Rating Means
Severity Levels
- Contraindicated These should generally not be used together.
- Major Potentially serious — often needs a change or close monitoring.
- Moderate Can be significant — usually manageable with monitoring. This interaction.
- Minor Usually limited clinical impact.
Evidence Grades
- EstablishedWell documented — supported by controlled studies or strong clinical data.
- ProbableGood supporting evidence, though not definitively proven.
- SuspectedSome evidence suggests this interaction, but it is not well established.
- PossibleLimited or conflicting evidence; the interaction may occur.
- TheoreticalExpected from how the drugs work, or from studies of similar drugs; this exact pair has little direct study. This interaction.
How Soon It Shows
- RapidEffects can appear quickly, often within about 24 hours of combining the drugs.
- DelayedEffects tend to build up gradually over days to weeks.
- UnspecifiedThe timing of this interaction is not well characterized. This interaction.
Ratings come from the documented interaction literature and are reviewed by a pharmacist. They describe the documented risk of the combination, not what will necessarily happen to you — your dose, timing, and health picture all matter.